Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Kainos, Wise

(Sharecast News) - Analysts at Berenberg hiked their target price on software firm Kainos from 1,260.0p to 1,415.0p on Tuesday, citing "resilient profits" and a "positive outlook". Kainos released its full-year results on Monday, which Berenberg said demonstrated its "bottom-line resilience", despite revenue coming in slightly below consensus.

Berenberg stated that although cyclical challenges in Kainos' services divisions will constrain growth in FY25, its Workday Products offering was performing "strongly" and that the medium- to long-term outlook for the business remains "overtly strong".

"While Kainos does not provide explicit guidance, CEO Russell Sloan noted that Kainos is positioned for 'substantial growth opportunities in both the near and medium term'. We think that challenges remain, with revenues from the Digital Services division's commercial sector expected to see 'modest reductions' in FY25. However, revenue from the healthcare sector, which declined 11% in FY24, is expected to return to growth. Meanwhile, revenues from the public sector and both Workday divisions (c80% of group revenues in total) are expected to see further growth in FY25," said Berenberg.

"Despite cyclical challenges in its services divisions and the short-term disruption of an impending UK general election, Kainos's long-term prospects remain undiminished and overtly positive, in our view."

The German bank added that Kainos trades on 23.9x full-year earnings per share and 23.3x enterprise value/free cash flow.

Barclays upgraded Wise on Tuesday to 'overweight' from 'equalweight' and lifted its price target on the stock to 1,000.0p from 800.0p.

"Wise's diversification offers sufficient levers to continue growth more than 20% mid-term at a circa 25% margin, even excluding excess NII," the bank said.

"Coupling underlying momentum with a short-term NII tailwind, we are 8/9% ahead of FY25/26 consensus earnings per share and see the de-rating as an opportunity to buy a high-quality compounder at a compelling valuation."

Share this article

Related Sharecast Articles

Broker tips: Halma, Genuit
(Sharecast News) - Analysts at Berenberg hiked their target price on safety equipment business Halma from 2,295.0p to 2,450.0p on Friday following the group's full-year earnings report a day earlier.
Broker tips: Victrex, Great Portland
(Sharecast News) - Analysts at Berenberg lowered their target price on high performance polymers business Victrex from 1,680.0p to 1,491.0p on Thursday, stating the group was "not out of the woods yet".
Broker tips: Whitbread, GB Group, Renew Holdings, Flutter Entertainment
(Sharecast News) - Jefferies reiterated its 'buy' rating on Whitbread but lowered its target price on the stock to 4,000.0p from 4,200.0p on the back of the hospitality firm's growth plans.
Broker tips: Intertek, GSK, HIkma Pharmaceuticals
(Sharecast News) - Analysts at Berenberg hiked their target price on quality assurance business Intertek from 5,400.0p to 5,500.0p on Tuesday, citing faster-than-expected margin accretion.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.